Additionally, the expression statuses of ezrin, ezrinThr-567 and ezrinTyr-353 proteins were not correlated with the survival rate in patients with advanced stage (III–IV) NSCLC (data not shown, P = 0.104, P = 0.288, P = 0.713, respectively, log-rank). This evidence concerns the gene EZR and non-small cell lung carcinoma.